查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1609075

次要大麻素市場：按產品、按應用分類 - 全球預測 2025-2030

Minor Cannabinoids Market by Products (Cannabichromene, Cannabigerol, Cannabigerolic Acid), Application (Cancer, Inflammation, Neurological Disorders) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年，次要大麻素市場價值為176.3億美元，預計到2024年將達到187.9億美元，複合年成長率為7.95%，到2030年將達到301.3億美元。

在快速成長的次要大麻素領域，大麻中發現的非精神活性和不太明顯的化合物，如 CBG、CBN、CBC 和 THCV，定義了市場範圍。這些大麻素因其潛在的治療作用而受到關注，增加了對藥品、食品和保健產品的需求。應用範圍從增強睡眠、調節食慾、緩解疼痛到潛在的發炎和神經保護特性，最終用途包括藥物配方、偏好、化妝品和寵物產品。消費者對自然保健療法的認知不斷提高、有利的監管變化以及大麻種植和萃取技術的進步對市場成長產生了重大影響。市場開拓機會比比皆是，包括開發有針對性的大麻素產品、臨床研究合作以及擴大新興和成熟合法市場的產品線。然而，市場面臨監管模糊、提取成本高以及長期影響臨床資料有限等挑戰，可能會阻礙快速商業化。為了利用新的商機，公司應該投資娛樂效果的研究。針對消費者行為和偏好的資料主導策略可以指南產品創新。此外，整合區塊鏈以提高供應鏈透明度和永續性可以提供競爭優勢。次要大麻素市場的性質是動態的，科學合作和不斷發展的立法朝著整體健康的角度增加了創新潛力。繼續倡導有利的法律規範以及產品品質和安全的標準化對於永續成長至關重要。創新的重點是最佳化萃取方法，透過精確的劑型來最大限度地發揮功效，以及開發針對特定健康結果的多種大麻素混合物。儘管面臨挑戰，但市場格局有望滿足不斷變化的消費者需求和技術進步的業務成長。

主要市場統計
基準年[2023] 176.3億美元
預測年份 [2024] 187.9億美元
預測年份 [2030] 301.3億美元
複合年成長率（%） 7.95%

市場動態：揭示快速發展的小型大麻素市場的關鍵市場洞察

供需的動態交互作用正在改變小規模大麻素市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 次要大麻素的醫療作用
    • 大麻素合法化的進展
    • 新的次要大麻素食品和飲料產品簡介
  • 市場限制因素
    • 次要大麻素高成本
  • 市場機會
    • 持續研究和開發次要大麻素
    • 資金籌措和投資以實現更好的商業化
  • 市場挑戰
    • 關於次要大麻素的嚴格規定

波特的五力：駕馭小型大麻素市場的策略工具

波特的五力框架是了解小大麻素市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解對次要大麻素市場的外部影響

外部宏觀環境因素在塑造次要大麻素市場的表現動態方面發揮關鍵作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解次要大麻素市場的競爭格局

對次要大麻素市場的詳細市場佔有率分析可以對供應商的業績進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 在次要大麻素市場的定位矩陣供應商績效評估

FPNV 定位矩陣是評估次要大麻素市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議繪製小大麻素市場的成功之路

小大麻素市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 次要大麻素的醫療益處
      • 大麻合法化取得進展
      • 新的次要大麻素食品和飲料產品簡介
    • 抑制因素
      • 次要大麻素的高成本
    • 機會
      • 持續研究和開發次要大麻素
      • 為更好的產品商業化提供資金和投資
    • 任務
      • 關於次要大麻素的嚴格規定
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 次要大麻素市場：依產品

  • 大麻色烯
  • 大麻醇
  • 大麻二酚酸
  • 大麻酚
  • 四氫大麻二酚

第7章 小型大麻素市場：依應用分類

  • 癌症
  • 發炎
  • 神經系統疾病
  • 疼痛管理

第8章美洲的小型大麻素市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太次要大麻素市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章 歐洲、中東和非洲的小型大麻素市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭場景分析
  • 戰略分析和建議

公司名單

  • Fresh Bros Hemp Company
  • GenCanna
  • Global Cannabinoids
  • Laurelcrest
  • Mile High labs International
  • Pacific Roots, LLC
  • Rhizo Sciences
  • Sanobiotec
  • Zero Point Extraction, LLC
Product Code: MRR-3A2E844FF091

The Minor Cannabinoids Market was valued at USD 17.63 billion in 2023, expected to reach USD 18.79 billion in 2024, and is projected to grow at a CAGR of 7.95%, to USD 30.13 billion by 2030.

In the burgeoning field of minor cannabinoids, the market scope is defined by non-psychoactive and less prominent compounds found in cannabis, such as CBG, CBN, CBC, and THCV. These cannabinoids are gaining attention due to their potential therapeutic benefits, increasing their necessity in pharmaceuticals, nutraceuticals, and wellness products. Applications extend from sleep enhancement, appetite regulation, and pain relief to potential anti-inflammatory and neuroprotective effects, with end-use spanning medicinal formulations, edibles, cosmetics, and pet products. Market growth is significantly influenced by increasing consumer awareness of natural health remedies, favorable regulatory shifts, and advancements in cannabis cultivation and extraction technologies. Opportunities abound in the development of targeted cannabinoid products, partnerships aimed at clinical research, and expanding product lines in both emerging and established legal markets. However, the market faces challenges such as regulatory ambiguity, high extraction costs, and limited clinical data on long-term effects, which could hamper rapid commercialization. To capitalize on emerging opportunities, companies should invest in research focused on the entourage effect, which examines how minor cannabinoids interact with major ones for enhanced benefits. Data-driven strategies targeting consumer behavior and preferences could guide product innovation. Moreover, integrating blockchain for supply chain transparency and sustainability could offer competitive advantages. The nature of the minor cannabinoids market is dynamic, with high innovation potential driven by scientific collaborations and evolving legislations geared towards holistic health perspectives. Continued advocacy for favorable regulatory frameworks and the standardization of product quality and safety will be crucial for sustained growth. Innovation should center around optimizing extraction methods, maximizing efficacy through precise dosage forms, and developing multi-cannabinoid blends tailored to specific health outcomes. The market landscape promises growth for businesses attuned to evolving consumer needs and technological advancements, despite the presence of challenges.

KEY MARKET STATISTICS
Base Year [2023] USD 17.63 billion
Estimated Year [2024] USD 18.79 billion
Forecast Year [2030] USD 30.13 billion
CAGR (%) 7.95%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Minor Cannabinoids Market

The Minor Cannabinoids Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Medical benefits of minor cannabinoids
    • Increasing legalization of cannabinoids
    • Introduction of new minor-cannabinoid food & beverage products
  • Market Restraints
    • High cost of minor cannabinoids
  • Market Opportunities
    • Ongoing R&D of minor cannabinoids
    • Funding and investments for better product commercialization
  • Market Challenges
    • Strict regulations regarding minor cannabinoids

Porter's Five Forces: A Strategic Tool for Navigating the Minor Cannabinoids Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Minor Cannabinoids Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Minor Cannabinoids Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Minor Cannabinoids Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Minor Cannabinoids Market

A detailed market share analysis in the Minor Cannabinoids Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Minor Cannabinoids Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Minor Cannabinoids Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Minor Cannabinoids Market

A strategic analysis of the Minor Cannabinoids Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Minor Cannabinoids Market, highlighting leading vendors and their innovative profiles. These include Fresh Bros Hemp Company, GenCanna, Global Cannabinoids, Laurelcrest, Mile High labs International, Pacific Roots, LLC, Rhizo Sciences, Sanobiotec, and Zero Point Extraction, LLC.

Market Segmentation & Coverage

This research report categorizes the Minor Cannabinoids Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Products, market is studied across Cannabichromene, Cannabigerol, Cannabigerolic Acid, Cannabinol, and Tetrahydrocannabivarin.
  • Based on Application, market is studied across Cancer, Inflammation, Neurological Disorders, and Pain Management.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Medical benefits of minor cannabinoids
      • 5.1.1.2. Increasing legalization of cannabinoids
      • 5.1.1.3. Introduction of new minor-cannabinoid food & beverage products
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of minor cannabinoids
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing R&D of minor cannabinoids
      • 5.1.3.2. Funding and investments for better product commercialization
    • 5.1.4. Challenges
      • 5.1.4.1. Strict regulations regarding minor cannabinoids
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Minor Cannabinoids Market, by Products

  • 6.1. Introduction
  • 6.2. Cannabichromene
  • 6.3. Cannabigerol
  • 6.4. Cannabigerolic Acid
  • 6.5. Cannabinol
  • 6.6. Tetrahydrocannabivarin

7. Minor Cannabinoids Market, by Application

  • 7.1. Introduction
  • 7.2. Cancer
  • 7.3. Inflammation
  • 7.4. Neurological Disorders
  • 7.5. Pain Management

8. Americas Minor Cannabinoids Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Minor Cannabinoids Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Minor Cannabinoids Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Fresh Bros Hemp Company
  • 2. GenCanna
  • 3. Global Cannabinoids
  • 4. Laurelcrest
  • 5. Mile High labs International
  • 6. Pacific Roots, LLC
  • 7. Rhizo Sciences
  • 8. Sanobiotec
  • 9. Zero Point Extraction, LLC

LIST OF FIGURES

  • FIGURE 1. MINOR CANNABINOIDS MARKET RESEARCH PROCESS
  • FIGURE 2. MINOR CANNABINOIDS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL MINOR CANNABINOIDS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL MINOR CANNABINOIDS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL MINOR CANNABINOIDS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS MINOR CANNABINOIDS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS MINOR CANNABINOIDS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES MINOR CANNABINOIDS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES MINOR CANNABINOIDS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC MINOR CANNABINOIDS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC MINOR CANNABINOIDS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA MINOR CANNABINOIDS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA MINOR CANNABINOIDS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. MINOR CANNABINOIDS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. MINOR CANNABINOIDS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. MINOR CANNABINOIDS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL MINOR CANNABINOIDS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL MINOR CANNABINOIDS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL MINOR CANNABINOIDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. MINOR CANNABINOIDS MARKET DYNAMICS
  • TABLE 7. GLOBAL MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL MINOR CANNABINOIDS MARKET SIZE, BY CANNABICHROMENE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL MINOR CANNABINOIDS MARKET SIZE, BY CANNABIGEROL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL MINOR CANNABINOIDS MARKET SIZE, BY CANNABIGEROLIC ACID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL MINOR CANNABINOIDS MARKET SIZE, BY CANNABINOL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL MINOR CANNABINOIDS MARKET SIZE, BY TETRAHYDROCANNABIVARIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL MINOR CANNABINOIDS MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL MINOR CANNABINOIDS MARKET SIZE, BY INFLAMMATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL MINOR CANNABINOIDS MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL MINOR CANNABINOIDS MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS MINOR CANNABINOIDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. BRAZIL MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. CANADA MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 26. CANADA MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. MEXICO MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 28. MEXICO MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. UNITED STATES MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 30. UNITED STATES MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. UNITED STATES MINOR CANNABINOIDS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 32. ASIA-PACIFIC MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 33. ASIA-PACIFIC MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. ASIA-PACIFIC MINOR CANNABINOIDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 35. AUSTRALIA MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 36. AUSTRALIA MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. CHINA MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 38. CHINA MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. INDIA MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 40. INDIA MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. INDONESIA MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 42. INDONESIA MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. JAPAN MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 44. JAPAN MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. MALAYSIA MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 46. MALAYSIA MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. PHILIPPINES MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 48. PHILIPPINES MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. SINGAPORE MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 50. SINGAPORE MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. SOUTH KOREA MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 52. SOUTH KOREA MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. TAIWAN MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 54. TAIWAN MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. THAILAND MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 56. THAILAND MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. VIETNAM MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 58. VIETNAM MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 60. EUROPE, MIDDLE EAST & AFRICA MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. EUROPE, MIDDLE EAST & AFRICA MINOR CANNABINOIDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 62. DENMARK MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 63. DENMARK MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. EGYPT MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 65. EGYPT MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. FINLAND MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 67. FINLAND MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. FRANCE MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 69. FRANCE MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. GERMANY MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 71. GERMANY MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. ISRAEL MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 73. ISRAEL MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. ITALY MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 75. ITALY MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. NETHERLANDS MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 77. NETHERLANDS MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. NIGERIA MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 79. NIGERIA MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. NORWAY MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 81. NORWAY MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. POLAND MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 83. POLAND MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. QATAR MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 85. QATAR MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. RUSSIA MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 87. RUSSIA MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. SAUDI ARABIA MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 89. SAUDI ARABIA MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH AFRICA MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH AFRICA MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. SPAIN MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 93. SPAIN MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. SWEDEN MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 95. SWEDEN MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. SWITZERLAND MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 97. SWITZERLAND MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. TURKEY MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 99. TURKEY MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED ARAB EMIRATES MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED ARAB EMIRATES MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED KINGDOM MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 103. UNITED KINGDOM MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. MINOR CANNABINOIDS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 105. MINOR CANNABINOIDS MARKET, FPNV POSITIONING MATRIX, 2023